Date published: 2026-2-14

1-800-457-3801

SCBT Portrait Logo
Seach Input

Olfr393 Inhibitors

Or1e33, a member of the olfactory receptor family 1 subfamily E in Mus musculus, plays a fundamental role in the intricate process of olfaction. Functioning as a G-protein-coupled receptor (GPCR), Or1e33 is a crucial mediator in the detection and transduction of odorant signals. Olfactory receptors like Or1e33 share a common structural feature of a 7-transmembrane domain, akin to other neurotransmitter and hormone receptors, underscoring their role as molecular switches in signal transduction pathways. The orchestrated interplay of these receptors is essential for the initiation of neuronal responses that culminate in the perception of distinct smells. The primary function of Or1e33 lies in its interaction with odorant molecules in the nasal cavity. This interaction triggers a neuronal response, initiating a cascade of events leading to the perception of a specific odor. As a GPCR, Or1e33 is integral to the recognition and transduction of these odorant signals through G protein-mediated pathways. The olfactory receptor gene family, of which Or1e33 is a part, stands out as the largest in the genome, underscoring the significance of these receptors in the olfactory system. The nomenclature assigned to olfactory receptor genes and proteins in this organism is independent of other species, highlighting the unique and species-specific nature of these molecular components.

In terms of inhibition, targeting Or1e33 involves modulating its intricate signaling pathways. The inhibitors identified exhibit diverse mechanisms that impact various stages of the olfactory signal transduction process. These mechanisms include interference with tyrosine kinase activity, phosphodiesterase inhibition leading to elevated cAMP levels, non-selective beta-blockade influencing GPCR activity, calcium channel blocking affecting intracellular processes, muscarinic acetylcholine receptor antagonism potentially influencing Or1e33 signaling, and modulation of key kinases such as p38 MAPK and PI3K. These inhibitors, by affecting distinct elements of the signaling cascade, provide valuable insights into potential modulators of Or1e33, shedding light on the regulatory intricacies of olfactory receptor function. The comprehensive exploration of these inhibitors expands our understanding of the molecular mechanisms underlying olfaction and opens avenues for further research into the precise regulation of Or1e33 and its role within the broader olfactory receptor gene family.

SEE ALSO...

Items 1 to 10 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Rolipram

61413-54-5sc-3563
sc-3563A
5 mg
50 mg
$77.00
$216.00
18
(1)

Phosphodiesterase inhibitor elevating cAMP levels, indirectly affecting Or1e33.

Carvedilol

72956-09-3sc-200157
sc-200157A
sc-200157B
sc-200157C
sc-200157D
100 mg
1 g
10 g
25 g
100 g
$124.00
$240.00
$530.00
$999.00
$1530.00
2
(1)

Non-selective beta-blocker influencing GPCR activity and modulating Or1e33 responsiveness.

Nifedipine

21829-25-4sc-3589
sc-3589A
1 g
5 g
$59.00
$173.00
15
(1)

Calcium channel blocker affecting intracellular processes related to Or1e33.

Atropine

51-55-8sc-252392
5 g
$204.00
2
(1)

Muscarinic acetylcholine receptor antagonist with potential impact on Or1e33 signaling.

SB 203580

152121-47-6sc-3533
sc-3533A
1 mg
5 mg
$90.00
$349.00
284
(5)

p38 MAPK inhibitor potentially influencing pathways associated with Or1e33.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$123.00
$400.00
148
(1)

PI3K inhibitor affecting downstream signaling pathways related to Or1e33.

Wortmannin

19545-26-7sc-3505
sc-3505A
sc-3505B
1 mg
5 mg
20 mg
$67.00
$223.00
$425.00
97
(3)

Phosphoinositide 3-kinase (PI3K) inhibitor, potentially modulating Or1e33 activity.

Heparin

9005-49-6sc-507344
25 mg
$119.00
1
(0)

Anticoagulant with potential indirect effects on Or1e33 responsiveness.

BAPTA/AM

126150-97-8sc-202488
sc-202488A
25 mg
100 mg
$138.00
$458.00
61
(2)

Intracellular calcium chelator that may influence GPCR-mediated events related to Or1e33.

Vandetanib

443913-73-3sc-220364
sc-220364A
5 mg
50 mg
$167.00
$1353.00
(1)

Inhibitor targeting vascular endothelial growth factor receptor (VEGFR) with potential impacts on Or1e33.